146 References Schutter, D. J. L. ., & van Honk, J. (2004). Decoupling of midfrontal delta–beta oscillations after testosterone administration. International Journal of Psychophysiology, 53(1), 71–73. https:// doi.org/10.1016/j.ijpsycho.2003.12.012 Schutter, D. J. L. G., & Van Honk, J. (2005). Salivary cortisol levels and the coupling of midfrontal delta-beta oscillations. International Journal of Psychophysiology, 55(1), 127–129. https://doi. org/10.1016/j.ijpsycho.2004.07.003 Sellers, J. G., Mehl, M. R., & Josephs, R. A. (2007). Hormones and personality: Testosterone as a marker of individual differences. Journal of Research in Personality, 41(1), 126–138. https://doi. org/https://doi.org/10.1016/j.jrp.2006.02.004 Shamay-Tsoory, S. G., & Abu-Akel, A. (2016). The Social Salience Hypothesis of Oxytocin. Biological Psychiatry, 79(3), 194–202. https://doi.org/10.1016/j.biopsych.2015.07.020 Sheehan, D. V, Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., … Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, Vol. 59, pp. 22–33. US: Physicians Postgraduate Press. Simmons, J. P., & Simonsohn, U. (2017). Power Posing : P-Curving the Evidence. Psychological Science, 28(5), 687–693. Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015). Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. Pharmacology & Therapeutics, 149, 150–190. https://doi.org/https://doi.org/10.1016/j. pharmthera.2014.12.004 Singmann, H. (2013). afex: analysis of Factorial Experiments. R package version 0.7-90. Sloan, T., & Telch, M. J. (2002). The effects of safety-seeking behavior and guided threat reappraisal on fear reduction during exposure: An experimental investigation. Behaviour Research and Therapy, 40(3), 235–251. https://doi.org/10.1016/S0005-7967(01)00007-9 Smith, J. (2012). Single-Case Experimental Designs: A Systematic Review of Published Research and Current Standards. Psychological Methods, 17(4), 1–7. https://doi.org/10.1037/a0029312.Single-Case Smits, J. A. J., Pollack, M. H., Rosenfield, D., Otto, M. W., Dowd, S., Carpenter, J., & Dutcher, C. D. (2020). Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder A Randomized Clinical Trial. JAMA Network Open, 3(6), 1–13. https://doi.org/10.1001/jamanetworkopen.2020.6777 Smits, J. A. J., Rosenfield, D., Davis, M. L., Julian, K., Handelsman, P. R., Otto, M. W., … Powers, M. B. (2013). Yohimbine Enhancement of Exposure Therapy for Social Anxiety Disorder: A Randomized Controlled Trial. Biological Psychiatry, 75(11), 840–846. https://doi.org/10.1016/j.biopsych.2013.10.008 Smits, J. A. J., Rosenfield, D., Otto, M. W., Powers, M. B., Hofmann, S. G., Telch, M. J., … Tart, C. D. (2013a). D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: Evidence from the treatment of height phobia. Biological Psychiatry, 73(11), 1054–1058. https://doi.org/10.1016/j.biopsych.2012.12.009
RkJQdWJsaXNoZXIy MTk4NDMw